Abstract:Background/Objective: Hematoma expansion (HE) predicts poor outcome and is an appealing treatment target in spontaneous intracerebral hemorrhage (ICH). Clinical evidence has shown an association of HE with peripheral white blood cells (WBC) count, but the individual contributions of leukocyte subtypes between literatures are described inconsistently. Our aim was to determine the relationship between admission absolute and differential leukocyte counts and HE by using different growth definitions. Methods: We analyzed spontaneous ICH patients who underwent baseline cranial computed tomography and blood sampling within 6 h of stroke onset in our institution between September 2013 and August 2018. Hematoma volume was calculated using a semiautomated 3-dimensional reconstruction algorithm. According to commonly used absolute or relative growth definitions (>6 mL, >12.5 mL, or >33%), we defined 5 types of HE. A propensity score-matching analysis was performed to evaluate the influence of complete blood count components on HE across the various growth definitions. The receiver operating characteristic analysis assessed the predictive ability of leukocyte counts for HE. Results: A total of 1,066 patients were included, of whom 11-21% met the 5 HE definitions. After propensity score-matching, except using the definition of >12.5 mL growth or its combination with >33% growth, both WBC and neutrophil count were independently associated with reduced risk of HE (odds ratio [OR] for 10(3) cells increase; OR, 0.86-0.99; all p < 0.05) after adjusting confounders in multivariate analyses. However, monocyte count was correlated with increased risk of HE under the usage of >12.5 mL expansion definition only (OR, 1.43; p = 0.024). There was no association between lymphocyte count and HE (all p > 0.05). Regardless of the growth definition, admission eosinophil count was directly associated with the risk of HE (OR, 6.92-31.60; all p < 0.05), and was the best predictive subtype with area under the curve 0.64, sensitivity 69.5%, and specificity 58.9% at the optimal cut-off value of 45 cells/mu L. Conclusions: Growth definition affects the relationship of HE with leukocyte subtypes counting. Eosinophil count robustly predicts HE, and may be a surrogate when using an inflammatory marker to help select acute ICH patients with high expansion risk for hemostasis treatment in clinical trial and practice.

Letter: Diseases in the tropics.

Determination of the lifetime width of the argon L1-hole state.

Multimodality MR imaging findings of low-grade brain edema in hepatic encephalopathy.

The neurogliovascular unit in hepatic encephalopathy

The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy

New Insights on Mechanisms and Therapeutic Targets of Cerebral Edema

Hepatic encephalopathy – recent advances in treatment and diagnosis

Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis

Elucidating hippocampal proteome dynamics in moderate hepatic encephalopathy rats: insights from high-resolution mass spectrometry

The assessment and management of cirrhotic patients with encephalopathy

Emerging therapeutic targets for cerebral edema

Brain edema in diseases of different etiology

Infection, inflammation and hepatic encephalopathy from a clinical perspective

Molecular, Pathological, Clinical, and Therapeutic Aspects of Perihematomal Edema in Different Stages of Intracerebral Hemorrhage

Pathophysiology of hepatic encephalopathy: The concept of synergism

A test for fibrinolytic capacity.

Multimodality Magnetic Resonance Imaging in Hepatic Encephalopathy: an Update.

Navigating the Gut-brain Axis: Insights into the Pathogenesis of Hepatic Encephalopathy

Design and Implementation of Digital Forensic Software for iPhone

Hepatic encephalopathy: From novel pathogenesis mechanism to emerging treatments

Association Between Eosinophilic Leukocyte Count and Hematoma Expansion in Acute Spontaneous Intracerebral Hemorrhage.